The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 21, 2019
Filed:
Dec. 11, 2015
Applicant:
Zenith Epigenetics Ltd., Calgary, CA;
Inventors:
Samuel David Brown, San Carlos, CA (US);
Craig Alan Coburn, San Rafael, CA (US);
Olesya Kharenko, Calgary, CA;
Assignee:
Zenith Epigenetics Ltd., Calgary, Alberta, CA;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4178 (2006.01); A61K 31/4196 (2006.01); A61K 31/422 (2006.01); A61K 31/4245 (2006.01); C07D 403/04 (2006.01); C07D 413/04 (2006.01); A61K 31/4184 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01); A61K 31/4439 (2006.01); A61K 31/4985 (2006.01); C07D 403/14 (2006.01); A61K 31/42 (2006.01); A61K 31/437 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/498 (2006.01); A61K 31/517 (2006.01); A61K 31/52 (2006.01); A61K 31/5377 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61K 45/06 (2006.01); C07D 471/04 (2006.01); C07D 473/34 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); A61K 31/4196 (2013.01); A61K 31/42 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61K 31/498 (2013.01); A61K 31/4985 (2013.01); A61K 31/517 (2013.01); A61K 31/52 (2013.01); A61K 31/5377 (2013.01); A61P 35/00 (2018.01); A61P 37/00 (2018.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 413/14 (2013.01); A61K 45/06 (2013.01); A61K 2300/00 (2013.01); C07D 413/04 (2013.01); C07D 471/04 (2013.01); C07D 473/34 (2013.01); Y02A 50/467 (2018.01);
Abstract
The present application relates to substituted heterocycles compound of Formula I and pharmaceutical compositions thereof useful for the inhibition of BET protein function by binding to bromodomains (Formula I).